Caris Raises $180M in Series D

Caris has successfully raised $180M in a Series D at a $1.2B valuation led by Sixth Street Partners.

Company Overview

Caris is a HealthTech company headquartered in Irving, TX, founded in 2008 with 1000+ employees.

Precision medicine and diagnostics

Fundraising Details

• Amount Raised: $180M
• Round Type: Series D
• Valuation: $1.2B
• Date: 2025-09-27
• Investors: Sixth Street Partners

About Caris

Precision medicine and diagnostics The company is positioned in the HealthTech sector, serving a growing market with innovative solutions.

Key Information

• Headquarters: Irving, TX
• Founded: 2008
• Team Size: 1000+
• Industry: HealthTech

What This Means

This funding round demonstrates strong investor confidence in Caris's vision and execution. The capital will likely be used to:

• Scale Operations: Expand the team and operational capacity
• Product Development: Enhance existing products and develop new features
• Market Expansion: Enter new markets and strengthen presence in existing ones
• Technology Investment: Invest in infrastructure and technology capabilities

Industry Context

The HealthTech sector continues to attract significant investment as companies innovate to meet evolving market demands. Caris's successful fundraising reflects the strong fundamentals and growth potential in this space.

Valuation Milestone

Reaching a $1.2B valuation marks an important milestone for Caris, positioning the company among notable players in the HealthTech industry.

Looking Ahead

With this new capital, Caris is well-positioned to execute on its growth strategy and continue building innovative solutions in the HealthTech space. The company's trajectory will be one to watch as it deploys this funding to achieve its next phase of growth.

This fundraising news was reported on 2025-09-27. For more information about Caris, visit their headquarters at Irving, TX.